Is anyone working on this? I am interested in using cloud computing for a de novo Solexa assembly of mammal transcriptome. Looked at Amazon, but they will only dedicate ~15gb RAM per instance/user.
Any ideas? Matt
Any ideas? Matt
-
-
Would it be possible to start up multiple instances and cluster them so they share the RAM? I could be talking rubbish though, as I'm not well versed in EC2 or computing clusters!
There's a test program in the Amazon Elastic Map Reduce called CloudBurst which is supposed to do short read mapping to a reference genome, although I haven't used it, I've only seen the paper. The Amazon info for it is at http://developer.amazonwebservices.c...xternalID=2272. -
That is pretty cool. I'd love to get together a more complete userguide for launching EC2 instances for beginners (myself included).
I know of another similar cloud project that is getting ready to launch...maybe that time is getting closer!
Comment
-
I am starting to look into this, I'll let you guys know if I get anywhere.--
Senthil PalanisamiComment
-
Hi Matt,
I've talked to Amazon Web Services and it sounds like a viable option for running a distributed-RAM method like ABySS. Pretty affordable too. They recommended a contractor to me who has experience setting up MPI-enabled jobs on EC2 which would be necessary to do ABySS.
I believe they are also going to get some larger-RAM machines available in the near future.
Best,
KristenComment
-
-
Hi,
You can use the "High-Memory Quadruple Extra Large Instance" instance type, which comes with 64GB of RAM and costs $1.8 per hour:
For prices, see http://aws.amazon.com/ec2/pricing/Comment
-
Hi,
If there are enough interests on a user guide on how to get starting with Amazon EC2, I can put one together.
QComment
-
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...Today, 09:55 AM -
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...
Comment